Dr. Camille Adeimy, MD

Dr. Adeimy practices at Kaiser Permanente Baldwin Park Medical Center in Baldwin Park, California, part of Kaiser Permanente.

Dr. Adeimy's NPI, 1477785160, was assigned on August 14, 2009. Dr. Adeimy graduated from American University of Beirut Faculty of Medicine in 2009. Dr. Adeimy holds California license A161191.

Dr. Adeimy's primary practice is Kaiser Permanente Baldwin Park Medical Center, at 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 in Los Angeles County. The practice phone is (626) 851-1011.

Dr. Adeimy's primary practice is Kaiser Permanente Baldwin Park Medical Center in Baldwin Park, California, part of Kaiser Permanente. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Adeimy to 1 more group practice or clinic, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adeimy practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Adeimy's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Adeimy is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Adeimy's licenses on file in 4 states: California, Illinois, Kansas and Missouri.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Adeimy treats.

CMS data shows 14 Medicare services from Dr. Adeimy across 1 procedure code in 2024, for 20 Medicare patients. Medicare paid $29 for them. Every service was in an office.

CMS counts 20 Medicare patients who saw Dr. Adeimy in 2024. The largest group is 75 to 84, with 0 patients. 60% of them have high blood pressure, and 55% have high cholesterol. Their average risk score is 3.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adeimy's median patient age at 65, with 64% women.

In 2024, Dr. Adeimy wrote 608 Medicare Part D claims for 134 patients. 82% of them were for generic drugs. CMS names the drug for 444 of them, across 14 drugs with 11 or more claims each, at $873,349 in total drug cost. In 2023, CMS named 257 claims across 10 drugs.

Dr. Adeimy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Adeimy, published from 2011 to 2022. Dr. Adeimy's most frequent co-authors are Stacy Wang Gray, MD, Mihaela Carmen Cristea, MD and James Yu Chang Shen, MD.

Dmand AI links Dr. Adeimy to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Rectal Diseases and Colorectal Neoplasms.

CMS Open Payments shows 220 general payments to Dr. Adeimy from 33 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $570.

Dr. Adeimy graduated from American University of Beirut Faculty of Medicine in 2009.

Dr. Adeimy is in network with 4 carriers, including Elevance, Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 2. Check the plan with the practice before a visit.